Event
ClinicalTrials.gov updates semaglutide obesity trial phase
Registry update notes a phase change for a semaglutide obesity study and keeps uncertainty visible.
CLINICAL_TRIAL_PHASE_CHANGEDEVELOPINGMODERATE
LifeWey
Life Sciences
Reading surface
Now
Registry update notes a phase change for a semaglutide obesity study and keeps uncertainty visible.
CLINICAL_TRIAL_PHASE_CHANGEDEVELOPINGMODERATE
What Happened
Registry update notes a phase change for a semaglutide obesity study and keeps uncertainty visible.
Evidence
NOW
ClinicalTrials.gov updates semaglutide obesity trial phase
Registry update notes a phase change for a semaglutide obesity study and keeps uncertainty visible.
CLINICAL_TRIAL_PHASE_CHANGEDEVELOPINGMODERATE
WHAT HAPPENED
Registry update notes a phase change for a semaglutide obesity study and keeps uncertainty visible.
Date: 2026-08-13Primary source: ClinicalTrials.gov
EVIDENCE
DEVELOPINGMODERATECLINICALTRIALS
Evidence is separated from significance. This event remains developing.
STAGE
OTHER CLINICALREGULATORY DOCUMENT
Study status: OTHER CLINICAL · Source type: REGULATORY DOCUMENT
WHY IT MATTERS
This updates the visible stage of a live study and changes how the trial should be read.
WHAT REMAINS UNKNOWN
A phase change does not itself report outcomes or independent replication.
RELATED ENTITIES
SOURCES
ClinicalTrials.govClinicalTrials.gov Study Updates
Family: CLINICALTRIALS · Authority: PRIMARY_SCIENTIFIC · https://clinicaltrials.gov/